Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (121-130 of 594) with videos related to

Pageof 60
Sort By:
Breast Cancer Research and Treatment|January 24, 2002
Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependentA B Tuck, C Hota, A F Chambers
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthDalit Barkan, Jeffrey E Green, Ann F Chambers
Antimicrobial Agents and Chemotherapy|May 1, 1997
Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37RaC J Hackbarth, I Unsal, H F Chambers
Antimicrobial Agents and Chemotherapy|December 1, 1991
Effect of protein binding of daptomycin on MIC and antibacterial activityB L Lee, M Sachdeva, H F Chambers
Breast Cancer Research : BCR|June 15, 2007
Tumour dormancy in breast cancer: an updateMuriel Brackstone, Jason L Townson, Ann F Chambers
Cancer Research|December 1, 1985
Experimental metastatic ability of H-ras-transformed NIH3T3 cellsG P Bondy, S Wilson, A F Chambers
The Journal of Clinical Investigation|July 1, 1985
Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillinH F Chambers, B J Hartman, A Tomasz
Antimicrobial Resistance and Infection Control|August 12, 2021
Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare systemEva Raphael, M Maria Glymour, Henry F Chambers
Antimicrobial Agents and Chemotherapy|January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactamsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
Antimicrobial Agents and Chemotherapy|November 1, 1994
Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureusC J Hackbarth, C Miick, H F Chambers
Pageof 60

Showing results (121-130 of 594) with videos related to

Sort By:
Pageof 60
Breast Cancer Research and Treatment|January 24, 2002
Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependentA B Tuck, C Hota, A F Chambers
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthDalit Barkan, Jeffrey E Green, Ann F Chambers
Antimicrobial Agents and Chemotherapy|May 1, 1997
Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37RaC J Hackbarth, I Unsal, H F Chambers
Antimicrobial Agents and Chemotherapy|December 1, 1991
Effect of protein binding of daptomycin on MIC and antibacterial activityB L Lee, M Sachdeva, H F Chambers
Breast Cancer Research : BCR|June 15, 2007
Tumour dormancy in breast cancer: an updateMuriel Brackstone, Jason L Townson, Ann F Chambers
Cancer Research|December 1, 1985
Experimental metastatic ability of H-ras-transformed NIH3T3 cellsG P Bondy, S Wilson, A F Chambers
The Journal of Clinical Investigation|July 1, 1985
Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillinH F Chambers, B J Hartman, A Tomasz
Antimicrobial Resistance and Infection Control|August 12, 2021
Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare systemEva Raphael, M Maria Glymour, Henry F Chambers
Antimicrobial Agents and Chemotherapy|January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactamsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
Antimicrobial Agents and Chemotherapy|November 1, 1994
Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureusC J Hackbarth, C Miick, H F Chambers
Pageof 60